Cite
MLA Citation
Sara M. Tolaney et al.. “Phase II and Biomarker Study of Cabozantinib in Metastatic Triple‐Negative Breast Cancer Patients.” Oncologist, vol. 22, 2017, pp. 25–32. http://access.bl.uk/ark:/81055/vdc_100045514537.0x000013
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sara M. Tolaney et al.. “Phase II and Biomarker Study of Cabozantinib in Metastatic Triple‐Negative Breast Cancer Patients.” Oncologist, vol. 22, 2017, pp. 25–32. http://access.bl.uk/ark:/81055/vdc_100045514537.0x000013